ETFChannel.com

REGN Price Target

Recent REGN Price   REGN Price Target
$742.30 REGN price target higher
+8.02%
$801.83
 As of 2023-01-27
Recent REGN Analyst Ratings Breakdown
  Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong buy ratings: 13 12 12 10
Buy ratings: 0 1 1 1
Hold ratings: 5 6 6 7
Sell ratings: 1 1 1 1
Strong sell ratings: 1 1 1 1
Average rating: 1.85 1.93 1.93 2.08
The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. For the REGN price target at the top of this page, we present the average REGN target price across the 18 analysts covering REGN, as reported in data provided by Zacks Investment Research via Quandl.com. The median REGN price target (a different metric than the average or mean) was $794.0 as of 2023-01-27, the highest REGN price target in the range was $970.0 while the lowest REGN price target in the range was $595.0, with a standard deviation of $89.012. Get the latest Zacks research report on REGN — FREE

Slideshow 10 ETFs With Most Upside To Analyst Targets
Slideshow Top 25 Broker Analyst Picks of the S&P 500

For ETFs, an interesting consideration with analyst target prices is that reaching the target price makes no difference to the ETF as far as deciding whether to continue to hold the stock. ETFs by nature are passive index-followers, so as long as the stock remains in the index, it doesn't much matter whether analysts find the stock overvalued or undervalued. Below are some of the ETFs that hold REGN at last report:

 ETF   REGN Weight   REGN Amount 
 VTI   0.19%   $2,302,013,504         
 VOO   0.24%   $1,841,666,754         
 QQQ   0.67%   $1,027,949,936         
 SPY   0.23%   $886,065,322         
 IVV   0.23%   $714,659,483         
 XLV   1.58%   $651,035,356         
 VTV   0.22%   $327,294,398         
 VUG   0.22%   $319,542,454         
 VHT   1.38%   $276,244,954         
 USMV   0.75%   $228,392,563         
List of all 123 ETFs holding REGN »
Company Name: 
Regeneron Pharmaceuticals, Inc.
Website: 
www.regeneron.com
Sector: 
Biotechnology
Number of ETFs Holding REGN: 
123
Total Market Value Held by ETFs: 
$10,643,742,615.62
Total Market Capitalization: 
$79,369,000,000
% of Market Cap. Held by ETFs: 
13.41%
Quotes delayed 20 minutes

Email EnvelopeFree REGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.15 out of 4)
35th percentile
(ranked lower than approx. 65% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com

REGN Price Target | www.ETFChannel.com

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.